CIK 0001660334
- Non-accelerated filer
- Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463137900
- Phone
- +1 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale 10% owner sold 14,305 shares at an average $11.26 ($161,099)
- 4 Open-market sale 10% owner sold 13,071 shares at an average $11.05 ($144,466)
- 4 Open-market sale 10% owner sold 13,544 shares at an average $11.33 ($153,483)
- 4 Open-market sale 10% owner sold 13,191 shares at an average $12.36 ($163,013)
- 4 Open-market sale 10% owner sold 13,057 shares at an average $13.53 ($176,676)
- 4 Open-market sale 10% owner sold 15,859 shares at an average $12.93 ($205,021)
- 4 Open-market sale 10% owner sold 10,298 shares at an average $11.95 ($123,109)
- 4 Gift Director gave 225,000 shares (gift)
- 4 Open-market sale 10% owner sold 10,220 shares at an average $10.94 ($111,841)
- 4 Open-market sale 10% owner sold 3,100 shares at an average $10.12 ($31,369)
- 4 Open-market sale 10% owner sold 5,765 shares at an average $10.26 ($59,171)
- 4 Open-market buy Chief Operating Officer bought 3,000 shares at $10.53 ($31,590)
- 4 Open-market sale 10% owner sold 8,019 shares at an average $10.53 ($84,472)
- 4 Open-market sale 10% owner sold 15,802 shares at an average $10.87 ($171,827)
- 4 Open-market buy Director bought 9,221 shares at an average $10.45 ($96,386)
- 4 Open-market buy Director bought 47,500 shares at an average $11.17 ($530,811)
- 4 Open-market sale 10% owner sold 33,276 shares at an average $9.80 ($326,259)
Page 11 of 13 · 253 filings